ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Clinical trial NCT05277402 · COMPLETED

Trial details

NCT number: NCT05277402
Sponsor: Adagene Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors

Start date: 2022-02-09
Primary completion: 2022-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.